Predictive value of melatonin and serotonin levels in early recovery period of cerebral ischemic hemispheric stroke

Authors

DOI:

https://doi.org/10.14739/2310-1237.2017.2.109292

Keywords:

cerebral infarction, serotonin, melatonin, prognosis

Abstract

The aim was developing of criteria for prediction of the early recovery period outcome of cerebral ischemic hemispheric stroke (CIHS) on the base of the identification of serum concentration of melatonin and plasma level of serotonin.

Materials and methods: complex clinical and paraclinical investigation was carried out in 77 patients (the average age of patients was 57.9 ± 0.9 years) on early recovery period of CHIS using of clinical scales (National Institute of Health Stroke Scale, Barthel Index, modified Rankin Scale) on the 10th, 30th, 90th and 180th day of disease, and visualization of cerebral structures by CT scan, and identification of the serum concentration of melatonin and serotonin plasma level on the 10th, 30th day of disease, and also by the calculation of the melatonin/serotonin ratio (MSR) as serum concentration of melatonin divided by serotonin plasma level.

Results. Using the comparative ROC-analysis it was defined that the most informative parameters for prediction of moderate and severe disability as for value according to mRS ≥ 3 points on the 180th day are the level of MSR on the 30th day (AUC = 0.78, p < 0.05), serotonin plasma level on the 30th day (AUC = 0.74, p < 0.05), dynamics of serum concentration of melatonin on the 30th day (AUC = 0.67, p < 0.05), dynamics of serotonin plasma level on the 30th day (AUC = 0.67, p < 0.05), dynamics of MSR on the 30th day (AUC = 0.66, p < 0.05) and serum concentration of melatonin on the 30th day (AUC = 0.66, p < 0.05).

Conclusions. The level of MSR ˃212,0 on the 30th day was the predictor of moderate and profound disability for modified Rankin's scale ≥3 points on the 90th (AUC = 0.81, p ˂ 0.05; sensitivity = 100.0 %, specificity = 75.0 %) and on the 180th day of disease was (AUC = 0.78, p ˂ 0.05; sensitivity = 100.0 %, specificity = 73.3 %); the serotonin plasma level ≤0.15 mcmol/l on the 30th day of CIHS was the predictor of moderate and profound disability for modified Rankin's scale ≥3 points on the 180th day of disease (AUC = 0.74, p ˂ 0.05; sensitivity = 60.0 %, specificity = 86.7 %).

References

Shilonosova, I. V. (2012) Serotonintransportnaya sistema v ostrejshem periode tyazhologo aterotromboticheskogo ishemicheskogo insul'ta [Serotonin a transport system in an acute period jf a serious atherothrombotic ischemic stroke]. Vrach-aspirant, 51(2.2), 335–339. [in Russian].

Reuter, B., Gumbinger, C., Sauer, T., Wiethölter, H., Bruder, I., Diehm, C., et al. (2016) Access, timing and frequency of very early stroke rehabilitation - insights from the Baden-Wuerttemberg stroke registry. BMC Neurol, 16, 222. doi: 10.1186/s12883-016-0744-7.

Wu, L., Wang, A., Wang, X., Zhao, X., Wang, C., Liu, L., et al. (2015) Factors for short-term outcomes in patients with a minor stroke: results from China National Stroke Registry. BMC Neurol, 15, 253. doi: 10.1186/s12883-015-0505-z.

Qin, L., Zhao, D., Xu, J., Ren, X., Terwilliger, E.F., Parangi, S., et al. (2013). The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin–1. Blood, 121(11), 2154–2164. doi: 10.1182/blood-2012-07-443903.

Juan, W. S., Huang, S. Y., Chang, C. C., Hung, Y. C., Lin, Y. W., Chen, T. Y., et al. (2014) Melatonin improves neuroplasticity by upregulating the growth-associated protein-43 (GAP-43) and NMDAR postsynaptic density-95 (PSD-95) proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal cerebral ischemia even during a long-term recovery period. J Pineal Res, 56(2), 213–223. doi: 10.1111/jpi.12114.

Chumboatong, W., Thummayot, S., Govitrapong, P., Tocharus, C., Jittiwat, J., & Tocharus, J. (2017) Neuroprotection of agomelatine against cerebral ischemia/reperfusion injury through an antiapoptotic pathway in rat. Neurochem Int, 102, 114–122. doi: 10.1016/j.neuint.2016.12.011.

Parada, E., Buendia, I., León, R., Negredo, P., Romero, A., Cuadrado, A., et al. (2014) Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression. J Pineal Res, 56(2), 204–212. doi: 10.1111/jpi.12113.

Sangha, R. S., Caprio, F. Z., Askew, R., Corado, C., Bernstein, R., Curran, Y., et al. (2015) Quality of life in patients with TIA and minor ischemic stroke. Neurology, 85(22), 1957–63. doi: 10.1212/WNL.0000000000002164.

Audhya, T., Adams, J. B., & Johansen, L. (2012) Correlation of serotonin levels in CSF, platelets, plasma, and urine. Biochim Biophys Acta, 820(10), 1496–501. doi: 10.1016/j.bbagen.2012.05.012.

Paterniti, I., Cordaro, M., Esposito, E., & Cuzzocrea, S. (2016) The antioxidative property of melatonin against brain ischemia. Expert Rev Neurother, 2016, 16(7), 841–848. doi: 10.1080/14737175.2016.1182020.

Downloads

How to Cite

1.
Medvedkova SO. Predictive value of melatonin and serotonin levels in early recovery period of cerebral ischemic hemispheric stroke. Pathologia [Internet]. 2017Sep.27 [cited 2024Mar.29];(2). Available from: http://pat.zsmu.edu.ua/article/view/109292

Issue

Section

Original research